← Open Payments lookup

JOHN RINK: Open Payments

NPI 1518184951 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$608 in 25 payments from 17 companies in 2025. Trend: 2023 $4,080 · 2024 $615 · 2025 $608

Food & beverage: $608
CompanyPaymentsAmount
GENZYME CORPORATION1$130
Celgene Corporation4$70
Daiichi Sankyo Inc.2$56
Janssen Biotech, Inc.3$55
Alexion Pharmaceuticals, Inc.2$40
Incyte Corporation2$40
SOBI, INC1$27
Syndax Pharmaceuticals, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$21
Caris MPI, Inc.1$21

Products named: AYVAKIT, Vanflyta, REBLOZYL, ULTOMIRIS, JAKAFI, Doptelet, NINLARO, MI CANCER SEEK.

Industry payments across LA — which companies pay providers there.